ADVANCEMENTS IN HEART FAILURE TREATMENT: EXPLORING THE ROLE OF GENE THERAPY
Keywords:
Heart failure, gene therapy, viral vectorsAbstract
Heart failure (HF) remains a major health challenge despite existing treatments. Gene therapy, which involves modifying genetic material within cells, has emerged as a promising approach to address the underlying causes of HF. Recent advancements in gene delivery techniques, including viral vectors, CRISPR, and RNA-based therapies, offer potential to repair cardiac tissue, enhance function, and slow disease progression. This review examines the role of gene therapy in HF treatment, highlighting recent research developments, clinical challenges, and future prospects for improving patient outcomes.
References
1. Jiang, X., et al. (2021). Gene Therapy in Cardiovascular Disease: Advances, Challenges, and Future Prospects. Journal of Cardiac Failure, 27(5), 418-429. https://doi.org/10.1016/j.cardfail.2021.03.003
2. Mendelsohn, M. E., & Karas, R. H. (2020). Cardiovascular Disease: Gene Therapy as a Novel Approach to Heart Failure. Nature Reviews Cardiology, 17(4), 255-268. https://doi.org/10.1038/s41569-019-0332-6
3. Foley, T. R., et al. (2022). CRISPR/Cas9 Gene Editing for Familial Cardiomyopathy: Potential and Limitations. Circulation Research, 130(9), 1275-1289. https://doi.org/10.1161/CIRCRESAHA.121.319031
4. Bresson, D., et al. (2021). RNA-Based Therapies in Heart Failure: Mechanisms and Clinical Applications. Nature Reviews Drug Discovery, 20(9), 596-612. https://doi.org/10.1038/s41573-021-00175-5
5. Krenning, G., et al. (2020). Gene Therapy Approaches to Cardiac Regeneration: Progress and Challenges. Journal of the American College of Cardiology, 75(18), 2297-2309. https://doi.org/10.1016/j.jacc.2020.02.031
6. Jadlowiec, J. A., et al. (2021). Fibrosis Inhibition in Heart Failure: Gene Therapy Strategies and Clinical Trials. Journal of Molecular Medicine, 99(12), 1819-1832. https://doi.org/10.1007/s00109-021-02096-2
7. Aslam, I. & Jiyanboyevich, Y.S. (2023). 'The common problem of international students and its solution and unexpected challenges of working with foreign teacher', Internationalization of Medical Education: Experience, Problems, Prospects, 66.
8. Jiyanboyevich, Y.S., Aslam, I. & Soatboyevich, J.N. (2024). 'Failure of the heart determination proteomic profiling related to patients who are elderly', Research Focus, 3(1), pp. 198-203.
9. Nodirovna, A.R., Maksudovna, M.M., Aslam, I. & Ergashboevna, A.Z. (2024). 'Evaluating novel anticoagulant and antiplatelet drugs for thromboembolic illness prevention and treatment', International Journal of Alternative and Contemporary Therapy, 2(5), pp. 135-141.
10. Shahzoda, K., Aslam, I., Ashraf, A., Ergashboevna, A.Z. & Ergashboevna, E.M. (2024). 'Advancements in surgical techniques: A comprehensive review', Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va rivojlanish omillari, 31(2), pp. 139-149.
11. Aslam, I. & Jiyanboyevich, Y.S. (2023). 'The common problem of international students and its solution and unexpected challenges of working with foreign teacher', Internationalization of Medical Education: Experience, Problems, Prospects, 66.
12. Nodirovna, A.R., Maksudovna, M.M., Aslam, I. & Ergashboevna, A.Z. (2024). 'Evaluating novel anticoagulant and antiplatelet drugs for thromboembolic illness prevention and treatment', International Journal of Alternative and Contemporary Therapy, 2(5), pp. 135-141.
13. Aslam, I., Jiyanboyevich, Y.S. & Rajabboevna, A.R. (2023). 'Apixaban vs Rivaroxaban blood thinner use reduced stroke and clot risk in patients with heart disease and arrhythmia', Rivista Italiana di Filosofia Analitica Junior, 14(2), pp. 883-889.
14. Aslam, I., Jiyanboyevich, Y.S. & Rajabboevna, A.R. (2023). 'Apixaban vs Rivaroxaban blood thinner use reduced stroke and clot risk in patients with heart disease and arrhythmia', Rivista Italiana di Filosofia Analitica Junior, 14(2), pp. 883-889.
15. Jiyanboyevich, Y.S., Aslam, I., Ravshanovna, M.U., Azamatovna, F.G. & Murodovna, J.D. (2021). 'Ventricular arrhythmias with congenital heart disease causing sudden death', NVEO-Natural Volatiles & Essential Oils Journal, pp. 2055-2063.
